Forecasts data is unavailable for this security.
Consensus recommendation
- 16-Nov-23
- 15-Aug-24
- 19-Sep-24
- 17-Oct-24
- 07-Nov-24
Select bar for recommendation details.
Recommendations | 07-Nov-24 | |
---|---|---|
Buy | 2 | |
Outperform | 4 | |
Hold | 3 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in USD
The 6 analysts offering 12 month price targets for Coherus Biosciences Inc have a median target of 7.50, with a high estimate of 23.00 and a low estimate of 1.50. The median estimate represents a 820.25% increase from the last price of 0.815.
High | 2,722.1% | 23.00 |
Med | 820.2% | 7.50 |
Low | 84.0% | 1.50 |
Earnings history & estimates in USD
The next earnings announcement is expected on Mar 11, 2025.
Average growth rate | +16.97% |
Average growth rate | -30.66% |
More ▼
Revenue history & estimates in USD
Average growth rate | +0.04% |
Average growth rate | -2.80% |
More ▼